Postoperative atrial fibrillation: mechanisms, manifestations and management
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lubitz, S. A. et al. Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation 131, 1648–1655 (2015).
Greenberg, J. W., Lancaster, T. S., Schuessler, R. B. & Melby, S. J. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur. J. Cardiothorac. Surg. 52, 665–672 (2017).
Aranki, S. F. et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94, 390–397 (1996).
Mathew, J. P. et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 276, 300–306 (1996).
Almassi, G. H. et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann. Surg. 226, 501–511 (1997).
Kowey, P. R. et al. Clinical outcome of patients who develop PAF after CABG surgery. Pacing Clin. Electrophysiol. 24, 191–193 (2001).
Soucier, R. J. et al. Predictors of conversion of atrial fibrillation after cardiac operation in the absence of class I or III antiarrhythmic medications. Ann. Thorac. Surg. 72, 694–697 (2001).
Hravnak, M., Hoffman, L. A., Saul, M. I., Zullo, T. G. & Whitman, G. R. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. Am. J. Crit. Care 11, 228–238 (2002).
Mathew, J. P. et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291, 1720–1729 (2004).
Izhar, U. et al. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study. J. Thorac. Cardiovasc. Surg. 129, 401–406 (2005).
Ahlsson, A., Fengsrud, E., Bodin, L. & Englund, A. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. Eur. J. Cardiothorac. Surg. 37, 1353–1359 (2010).
Steinberg, B. A. et al. Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. Clin. Cardiol. 37, 7–13 (2014).
Melduni, R. M. et al. Implications of new-onset atrial fibrillation after cardiac surgery on long-term prognosis: a community-based study. Am. Heart J. 170, 659–668 (2015).
Funk, M., Richards, S. B., Desjardins, J., Bebon, C. & Wilcox, H. Incidence, timing, symptoms, and risk factors for atrial fibrillation after cardiac surgery. Am. J. Crit. Care 12, 424–433; quiz 434–435 (2003).
Lee, J. K. et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Am. Heart J. 140, 871–877 (2000).
Gillinov, A. M. et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N. Engl. J. Med. 374, 1911–1921 (2016).
Hogue, C. W. Jr. et al. RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft surgery. Circulation 98, 429–434 (1998).
Echahidi, N., Pibarot, P., O’Hara, G. & Mathieu, P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J. Am. Coll. Cardiol. 51, 793–801 (2008).
Shantsila, E., Watson, T. & Lip, G. Y. Atrial fibrillation post-cardiac surgery: changing perspectives. Curr. Med. Res. Opin. 22, 1437–1441 (2006).
Ishii, Y. et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 111, 2881–2888 (2005).
Gaudino, M. et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 108, (Suppl. 1) II195–II199 (2003).
Hak, L. et al. Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG). J. Interferon Cytokine Res. 29, 327–332 (2009).
Bruins, P. et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96, 3542–3548 (1997).
Abdelhadi, R. H., Gurm, H. S., Van Wagoner, D. R. & Chung, M. K. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am. J. Cardiol. 93, 1176–1178 (2004).
Jongnarangsin, K. et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 19, 668–672 (2008).
Enc, Y. et al. Atrial fibrillation after surgical revascularization: is there any difference between on-pump and off-pump? Eur. J. Cardiothorac. Surg. 26, 1129–1133 (2004).
Legare, J. F. et al. Coronary bypass surgery performed off pump does not result in lower in-hospital morbidity than coronary artery bypass grafting performed on pump. Circulation 109, 887–892 (2004).
Lee, S. H. et al. New-onset atrial fibrillation predicts long-term newly developed atrial fibrillation after coronary artery bypass graft. Am. Heart J. 167, 593–600 (2014).
Miller, J. M. et al. Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J. Cardiovasc. Electrophysiol. 25, 921–929 (2014).
Body, S. C. et al. Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ. Cardiovasc. Genet. 2, 499–506 (2009).
Fuller, J. A., Adams, G. G. & Buxton, B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J. Thorac. Cardiovasc. Surg. 97, 821–825 (1989).
Lahtinen, J. et al. Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann. Thorac. Surg. 77, 1241–1244 (2004).
Likosky, D. S. et al. Intraoperative and postoperative variables associated with strokes following cardiac surgery. Heart Surg. Forum 7, E271–E276 (2004).
Gialdini, G. et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 312, 616–622 (2014).
Amar, D. et al. Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery. Chest 108, 349–354 (1995).
Vaporciyan, A. A. et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J. Thorac. Cardiovasc. Surg. 127, 779–786 (2004).
Passman, R. S. et al. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann. Thorac. Surg. 79, 1698–1703 (2005).
Merritt, R. E. & Shrager, J. B. Prophylaxis and management of atrial fibrillation after general thoracic surgery. Thorac. Surg. Clin. 22, 13–23 (2012).
Polanczyk, C. A., Goldman, L., Marcantonio, E. R., Orav, E. J. & Lee, T. H. Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann. Intern. Med. 129, 279–285 (1998).
Batra, G. S., Molyneux, J. & Scott, N. A. Colorectal patients and cardiac arrhythmias detected on the surgical high dependency unit. Ann. R. Coll. Surg. Engl. 83, 174–176 (2001).
Christians, K. K., Wu, B., Quebbeman, E. J. & Brasel, K. J. Postoperative atrial fibrillation in noncardiothoracic surgical patients. Am. J. Surg. 182, 713–715 (2001).
Walsh, S. R. et al. Postoperative arrhythmias in general surgical patients. Ann. R. Coll. Surg. Engl. 89, 91–95 (2007).
Sohn, G. H. et al. The incidence and predictors of postoperative atrial fibrillation after noncardiothoracic surgery. Korean Circ. J. 39, 100–104 (2009).
Bhave, P. D., Goldman, L. E., Vittinghoff, E., Maselli, J. & Auerbach, A. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am. Heart J. 164, 918–924 (2012).
Andrade, J., Khairy, P., Dobrev, D. & Nattel, S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ. Res. 114, 1453–1468 (2014).
Heijman, J., Guichard, J. B., Dobrev, D. & Nattel, S. Translational challenges in atrial fibrillation. Circ. Res. 122, 752–773 (2018).
Heijman, J., Voigt, N., Nattel, S. & Dobrev, D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ. Res. 114, 1483–1499 (2014).
Nattel, S. Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanisms. Can. J. Cardiol. 29, 1147–1149 (2013).
Maesen, B., Nijs, J., Maessen, J., Allessie, M. & Schotten, U. Post-operative atrial fibrillation: a maze of mechanisms. Europace 14, 159–174 (2012).
Dimmer, C. et al. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am. J. Cardiol. 82, 22–25 (1998).
Chen, P. S., Chen, L. S., Fishbein, M. C., Lin, S. F. & Nattel, S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ. Res. 114, 1500–1515 (2014).
Kalman, J. M. et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann. Thorac. Surg. 60, 1709–1715 (1995).
Feneck, R. O., Sherry, K. M., Withington, P. S. & Oduro-Dominah, A. The European Milrinone Multicenter Trial Group. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 15, 306–315 (2001).
Argalious, M. et al. “Renal dose” dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit. Care Med. 33, 1327–1332 (2005).
White, H. D. et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation 70, 479–484 (1984).
Lamb, R. K. et al. The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. Eur. Heart J. 9, 32–36 (1988).
Shen, M. J. et al. Simultaneous recordings of intrinsic cardiac nerve activity and skin sympathetic nerve activity from human patients during the postoperative period. Heart Rhythm 14, 1587–1593 (2017).
Amar, D., Zhang, H., Miodownik, S. & Kadish, A. H. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J. Am. Coll. Cardiol. 42, 1262–1268 (2003).
Pokushalov, E. et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one-year follow-up of a randomized pilot study. Circ. Arrhythm. Electrophysiol. 8, 1334–1341 (2015).
Alexandre, J. et al. Preoperative plasma aldosterone and the risk of atrial fibrillation after coronary artery bypass surgery: a prospective cohort study. J. Hypertens. 34, 2449–2457 (2016).
Chequel, M. et al. Preoperative plasma aldosterone levels and postoperative atrial fibrillation occurrence following cardiac surgery: a review of literature and design of the ALDO-POAF study (ALDOsterone for Prediction of Post-Operative Atrial Fibrillation). Curr. Clin. Pharmacol. 11, 150–158 (2016).
Fontes, M. L. et al. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth. Analg. 101, 17–23 (2005).
Amar, D., Goenka, A., Zhang, H., Park, B. & Thaler, H. T. Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery. Ann. Thorac. Surg. 82, 1057–1061 (2006).
Lamm, G. et al. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 20, 51–56 (2006).
Gibson, P. H. et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am. J. Cardiol. 105, 186–191 (2010).
Ucar, H. I. et al. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery. Heart Surg. Forum 10, E131–E135 (2007).
Pretorius, M. et al. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Circulation 116, I1–I7 (2007).
Canbaz, S., Erbas, H., Huseyin, S. & Duran, E. The role of inflammation in atrial fibrillation following open heart surgery. J. Int. Med. Res. 36, 1070–1076 (2008).
Girerd, N. et al. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur. Heart J. 30, 1270–1278 (2009).
Kaireviciute, D. et al. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. Thromb. Haemost. 104, 122–127 (2010).
Sandler, N. et al. Mitochondrial DAMPs are released during cardiopulmonary bypass surgery and are associated with postoperative atrial fibrillation. Heart Lung Circ. 27, 122–129 (2018).
Wu, Z. K. et al. High postoperative interleukin-8 levels related to atrial fibrillation in patients undergoing coronary artery bypass surgery. World J. Surg. 32, 2643–2649 (2008).
Kourliouros, A. et al. Substrate modifications precede the development of atrial fibrillation after cardiac surgery: a proteomic study. Ann. Thorac. Surg. 92, 104–110 (2011).
Jacob, K. A. et al. Inflammation in new-onset atrial fibrillation after cardiac surgery: a systematic review. Eur. J. Clin. Invest. 44, 402–428 (2014).
Goette, A. et al. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc. Res. 54, 390–396 (2002).
Del Campo, A. et al. Increased C-reactive protein plasma levels are not involved in the onset of post-operative atrial fibrillation. J. Cardiol. 70, 578–583 (2017).
Ho, K. M. & Tan, J. A. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation 119, 1853–1866 (2009).
Ryu, K. et al. Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 293, H1231–H1241 (2007).
Veleva, T. et al. Abstract: the role of the NLRP3 inflammasome in postoperative atrial fibrillation. Heart Rhythm 15, S189 (2018).
Yao, C. et al. Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation. Circulation 138, 2227–2242 (2018).
Scott, L. Jr., Li, N. & Dobrev, D. Role of inflammatory signaling in atrial fibrillation. Int. J. Cardiol. https://doi.org/10.1016/j.ijcard.2018.10.020 (2018).
Mommersteeg, M. T., Christoffels, V. M., Anderson, R. H. & Moorman, A. F. Atrial fibrillation: a developmental point of view. Heart Rhythm 6, 1818–1824 (2009).
Voigt, N. et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 129, 145–156 (2014).
Voigt, N. et al. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 125, 2059–2070 (2012).
Van Wagoner, D. R. et al. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ. Res. 85, 428–436 (1999).
Workman, A. J. et al. Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J. Cardiovasc. Electrophysiol. 17, 1230–1238 (2006).
Lezoualc’h, F. et al. Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillation. Biochem. Biophys. Res. Commun. 357, 218–224 (2007).
Swartz, M. F. et al. Left versus right atrial difference in dominant frequency, K+ channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery. Heart Rhythm 6, 1415–1422 (2009).
Zaman, J. A. et al. Post-operative atrial fibrillation is associated with a pre-existing structural and electrical substrate in human right atrial myocardium. Int. J. Cardiol. 220, 580–588 (2016).
Dobrev, D. et al. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc. Res. 54, 397–404 (2002).
Wang, G. D. et al. Relationship between integrated backscatter and atrial fibrosis in patients with and without atrial fibrillation who are undergoing coronary bypass surgery. Clin. Cardiol. 32, E56–E61 (2009).
Swartz, M. F. et al. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. J. Am. Coll. Cardiol. 60, 1799–1806 (2012).
Li, J. Y. et al. Atrial gap junctions, NF-kappaB and fibrosis in patients undergoing coronary artery bypass surgery: the relationship with postoperative atrial fibrillation. Cardiology 112, 81–88 (2009).
Muller, P. et al. Correlation between total atrial conduction time estimated via tissue Doppler imaging (PA-TDI Interval), structural atrial remodeling and new-onset of atrial fibrillation after cardiac surgery. J. Cardiovasc. Electrophysiol. 24, 626–631 (2013).
Tinica, G., Mocanu, V., Zugun-Eloae, F. & Butcovan, D. Clinical and histological predictive risk factors of atrial fibrillation in patients undergoing open-heart surgery. Exp. Ther. Med. 10, 2299–2304 (2015).
Ozben, B. et al. Postoperative atrial fibrillation after coronary artery bypass grafting surgery: a two-dimensional speckle tracking echocardiography study. Heart Lung Circ. 25, 993–999 (2016).
Grammer, J. B. et al. Atrial fibrosis in heart surgery patients Decreased collagen III/I ratio in postoperative atrial fibrillation. Basic Res. Cardiol. 100, 288–294 (2005).
Cosgrave, J. et al. Preoperative atrial histological changes are not associated with postoperative atrial fibrillation. Cardiovasc. Pathol. 15, 213–217 (2006).
Garcia, L. et al. Impaired cardiac autophagy in patients developing postoperative atrial fibrillation. J. Thorac. Cardiovasc. Surg. 143, 451–459 (2012).
Muller, P. et al. Increased preoperative serum apoptosis marker fas ligand correlates with histopathology and new-onset of atrial fibrillation in patients after cardiac surgery. J. Cardiovasc. Electrophysiol. 24, 1110–1115 (2013).
Barallobre-Barreiro, J. et al. Glycoproteomics reveals decorin peptides with anti-myostatin activity in human atrial fibrillation. Circulation 134, 817–832 (2016).
Simon, J. N., Ziberna, K. & Casadei, B. Compromised redox homeostasis, altered nitroso-redox balance, and therapeutic possibilities in atrial fibrillation. Cardiovasc. Res. 109, 510–518 (2016).
Anderson, E. J. et al. Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation. J. Am. Heart Assoc. 3, e000713 (2014).
Reilly, S. N. et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 124, 1107–1117 (2011).
Antoniades, C. et al. Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. J. Am. Coll. Cardiol. 59, 60–70 (2012).
Ad, N., Schneider, A., Khaliulin, I., Borman, J. B. & Schwalb, H. Impaired mitochondrial response to simulated ischemic injury as a predictor of the development of atrial fibrillation after cardiac surgery: in vitro study in human myocardium. J. Thorac. Cardiovasc. Surg. 129, 41–45 (2005).
Guler, N. et al. Do cardiac neuropeptides play a role in the occurrence of atrial fibrillation after coronary bypass surgery? Ann. Thorac. Surg. 83, 532–537 (2007).
Willeford, A. et al. CaMKIIδ-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis. JCI Insight 3, 97054 (2018).
Burashnikov, A. & Antzelevitch, C. Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation 107, 2355–2360 (2003).
Sigurdsson, M. I. et al. Post-operative atrial fibrillation examined using whole-genome RNA sequencing in human left atrial tissue. BMC Med. Genom. 10, 25 (2017).
Slagsvold, K. H., Rognmo, O., Hoydal, M., Wisloff, U. & Wahba, A. Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circ. Res. 114, 851–859 (2014).
Jayaram, R. et al. Molecular mechanisms of myocardial nitroso-redox imbalance during on-pump cardiac surgery. Lancet 385 (Suppl. 1), S49 (2015).
Jeganathan, J. et al. Mitochondrial dysfunction in atrial tissue of patients developing postoperative atrial fibrillation. Ann. Thorac. Surg. 104, 1547–1555 (2017).
Tsoporis, J. N. et al. Increased right atrial appendage apoptosis is associated with differential regulation of candidate MicroRNAs 1 and 133A in patients who developed atrial fibrillation after cardiac surgery. J. Mol. Cell. Cardiol. 121, 25–32 (2018).
Jeong, E. M. et al. Metabolic stress, reactive oxygen species, and arrhythmia. J. Mol. Cell. Cardiol. 52, 454–463 (2012).
Schuessler, R. B. et al. The effects of inflammation on heart rate and rhythm in a canine model of cardiac surgery. Heart Rhythm 9, 432–439 (2012).
Kumagai, K., Nakashima, H. & Saku, K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc. Res. 62, 105–111 (2004).
Tselentakis, E. V., Woodford, E., Chandy, J., Gaudette, G. R. & Saltman, A. E. Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J. Surg. Res. 135, 68–75 (2006).
Zhang, Z. et al. n-3 polyunsaturated fatty acids prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Int. J. Cardiol. 153, 14–20 (2011).
Zhang, Y. et al. Role of inflammation in the initiation and maintenance of atrial fibrillation and the protective effect of atorvastatin in a goat model of aseptic pericarditis. Mol. Med. Rep. 11, 2615–2623 (2015).
Fu, X. X. et al. Interleukin-17A contributes to the development of post-operative atrial fibrillation by regulating inflammation and fibrosis in rats with sterile pericarditis. Int. J. Mol. Med. 36, 83–92 (2015).
Huang, Z. et al. Signal transducer and activator of transcription 3/microRNA-21 feedback loop contributes to atrial fibrillation by promoting atrial fibrosis in a rat sterile pericarditis model. Circ. Arrhythm. Electrophysiol. 9, e003396 (2016).
Goldstein, R. N., Ryu, K., Khrestian, C., van Wagoner, D. R. & Waldo, A. L. Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model. J. Cardiovasc. Electrophysiol. 19, 74–81 (2008).
Yoo, D. et al. Adhesive epicardial corticosteroids prevent postoperative atrial fibrillation. Circ. Arrhythm. Electrophysiol. 3, 505–510 (2010).
Rossman, E. I. et al. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. J. Pharmacol. Exp. Ther. 329, 1127–1133 (2009).
Kumagai, K., Nakashima, H., Gondo, N. & Saku, K. Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model. J. Cardiovasc. Electrophysiol. 14, 880–884 (2003).
Sadrpour, S. A. et al. Termination of atrial flutter and fibrillation by K201’s metabolite M-II: studies in the canine sterile pericarditis model. J. Cardiovasc. Pharmacol. 65, 494–499 (2015).
Bhimani, A. A. et al. Ranolazine terminates atrial flutter and fibrillation in a canine model. Heart Rhythm 11, 1592–1599 (2014).
Goldstein, R. N., Khrestian, C., Carlsson, L. & Waldo, A. L. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model. J. Cardiovasc. Electrophysiol. 15, 1444–1450 (2004).
Shimizu, A. et al. Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model. J. Cardiovasc. Pharmacol. 21, 656–662 (1993).
Becker, R. et al. Suppression of atrial fibrillation by multisite and septal pacing in a novel experimental model. Cardiovasc. Res. 54, 476–481 (2002).
Matsumoto, N. et al. Vanoxerine, a new drug for terminating atrial fibrillation and flutter. J. Cardiovasc. Electrophysiol. 21, 311–319 (2010).
Cakulev, I. et al. Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results. J. Cardiovasc. Electrophysiol. 22, 1266–1273 (2011).
Arsenault, K. A. et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst. Rev. 1, CD003611 (2013).
Burgess, D. C., Kilborn, M. J. & Keech, A. C. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur. Heart J. 27, 2846–2857 (2006).
Al-Khatib, S. M. et al. Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial. Am. Heart J. 158, 792–798 (2009).
Zhao, B. C. et al. Prophylaxis against atrial fibrillation after general thoracic surgery: trial sequential analysis and network meta-analysis. Chest 151, 149–159 (2017).
Group, P. S. et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371, 1839–1847 (2008).
Mitchell, L. B. et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial. JAMA 294, 3093–3100 (2005).
Chatterjee, S., Sardar, P., Mukherjee, D., Lichstein, E. & Aikat, S. Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis. Pacing Clin. Electrophysiol. 36, 1017–1023 (2013).
Buckley, M. S. et al. Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy 27, 360–368 (2007).
Zhu, J. et al. Meta-analysis of amiodarone versus beta-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery. Intern. Med. J. 42, 1078–1087 (2012).
Auer, J. et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am. Heart J. 147, 636–643 (2004).
Nattel, S. The molecular and ionic specificity of antiarrhythmic drug actions. J. Cardiovasc. Electrophysiol. 10, 272–282 (1999).
Van Mieghem, W. et al. Amiodarone and the development of ARDS after lung surgery. Chest 105, 1642–1645 (1994).
Tisdale, J. E. et al. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. Ann. Thorac. Surg. 88, 886–893 (2009).
Riber, L. P., Christensen, T. D., Jensen, H. K., Hoejsgaard, A. & Pilegaard, H. K. Amiodarone significantly decreases atrial fibrillation in patients undergoing surgery for lung cancer. Ann. Thorac. Surg. 94, 339–344 (2012).
Khalil, M. A., Al-Agaty, A. E., Ali, W. G. & Abdel Azeem, M. S. A comparative study between amiodarone and magnesium sulfate as antiarrhythmic agents for prophylaxis against atrial fibrillation following lobectomy. J. Anesth. 27, 56–61 (2013).
Mooss, A. N. et al. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am. Heart J. 148, 641–648 (2004).
Wijeysundera, D. N., Beattie, W. S., Rao, V. & Karski, J. Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis. J. Am. Coll. Cardiol. 41, 1496–1505 (2003).
Van Mieghem, W. et al. Verapamil as prophylactic treatment for atrial fibrillation after lung operations. Ann. Thorac. Surg. 61, 1083–1085 (1996).
Amar, D. et al. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J. Thorac. Cardiovasc. Surg. 120, 790–798 (2000).
Ritchie, A. J., Bowe, P. & Gibbons, J. R. Prophylactic digitalization for thoracotomy: a reassessment. Ann. Thorac. Surg. 50, 86–88 (1990).
Kowey, P. R., Taylor, J. E., Rials, S. J. & Marinchak, R. A. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am. J. Cardiol. 69, 963–965 (1992).
Aguilar, M. & Nattel, S. Taking the pulse of atrial fibrillation: a practical approach to rate control. Can. J. Cardiol. 34, 1526–1530 (2018).
Ito, N. et al. Efficacy of propafenone hydrochloride in preventing postoperative atrial fibrillation after coronary artery bypass grafting. Heart Surg. Forum 13, E223–E227 (2010).
Morike, K. et al. Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial. Clin. Pharmacol. Ther. 84, 104–110 (2008).
Kowey, P. R., Yannicelli, D., Amsterdam, E. & Investigators, C.-I. Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting. Am. J. Cardiol. 94, 663–665 (2004).
Gold, M. R., O’Gara, P. T., Buckley, M. J. & DeSanctis, R. W. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Am. J. Cardiol. 78, 975–979 (1996).
Laub, G. W. et al. Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting: a prospective, double-blind, randomized, placebo-controlled pilot study. Crit. Care Med. 21, 1474–1478 (1993).
Borgeat, A. et al. Prevention of arrhythmias by flecainide after noncardiac thoracic surgery. Ann. Thorac. Surg. 48, 232–234 (1989).
Borgeat, A. et al. Prevention of arrhythmias after noncardiac thoracic operations: flecainide versus digoxin. Ann. Thorac. Surg. 51, 964–967; discussion 967–968 (1991).
Dobrev, D. & Nattel, S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 375, 1212–1223 (2010).
Serafimovski, N., Burke, P., Khawaja, O., Sekulic, M. & Machado, C. Usefulness of dofetilide for the prevention of atrial tachyarrhythmias (atrial fibrillation or flutter) after coronary artery bypass grafting. Am. J. Cardiol. 101, 1574–1579 (2008).
Nattel, S. Ionic determinants of atrial fibrillation and Ca2+ channel abnormalities: cause, consequence, or innocent bystander? Circ. Res. 85, 473–476 (1999).
Trivedi, C., Upadhyay, A. & Solanki, K. Efficacy of ranolazine in preventing atrial fibrillation following cardiac surgery: results from a meta-analysis. J. Arrhythm. 33, 161–166 (2017).
Burashnikov, A. & Antzelevitch, C. Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation. Future Cardiol. 7, 733–737 (2011).
Cook, R. C. et al. Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a meta-analysis. Ann. Thorac. Surg. 95, 533–541 (2013).
Cook, R. C. et al. Prophylactic intravenous magnesium sulphate in addition to oral {beta}-blockade does not prevent atrial arrhythmias after coronary artery or valvular heart surgery: a randomized, controlled trial. Circulation 120, S163–S169 (2009).
Terzi, A. et al. Prevention of atrial tachyarrhythmias after non-cardiac thoracic surgery by infusion of magnesium sulfate. Thorac. Cardiovasc. Surg. 44, 300–303 (1996).
Lennerz, C., Barman, M., Tantawy, M., Sopher, M. & Whittaker, P. Colchicine for primary prevention of atrial fibrillation after open-heart surgery: systematic review and meta-analysis. Int. J. Cardiol. 249, 127–137 (2017).
Imazio, M. et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA 312, 1016–1023 (2014).
Verma, S. et al. Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord. 15, 96 (2015).
Viviano, A., Kanagasabay, R. & Zakkar, M. Is perioperative corticosteroid administration associated with a reduced incidence of postoperative atrial fibrillation in adult cardiac surgery? Interact. Cardiovasc. Thorac. Surg. 18, 225–229 (2014).
Dieleman, J. M. et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 308, 1761–1767 (2012).
Whitlock, R. P. et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet 386, 1243–1253 (2015).
Zhen-Han, L. et al. Perioperative statin administration with decreased risk of postoperative atrial fibrillation, but not acute kidney injury or myocardial infarction: a meta-analysis. Sci. Rep. 7, 10091 (2017).
Amar, D. et al. Beneficial effects of perioperative statins for major pulmonary resection. J. Thorac. Cardiovasc. Surg. 149, 1532–1538 (2015).
Zheng, Z. et al. Perioperative rosuvastatin in cardiac surgery. N. Engl. J. Med. 374, 1744–1753 (2016).
Zhang, B., Zhen, Y., Tao, A., Bao, Z. & Zhang, G. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials. J. Cardiol. 63, 53–59 (2014).
Maisel, W. H., Epstein, A. E. & The American College of Chest Physicians. The role of cardiac pacing: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128, 36S–38S (2005).
Maaroos, M., Halonen, J., Kiviniemi, V., Hartikainen, J. & Hakala, T. Intravenous metoprolol versus biatrial pacing in the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized open trial. Scand. J. Surg. 101, 292–296 (2012).
Akbarzadeh, F., Kazemi-Arbat, B., Golmohammadi, A. & Pourafkari, L. Biatrial pacing versus intravenous amiodarone in prevention of atrial fibrillation after coronary artery bypass surgery. Pak. J. Biol. Sci. 12, 1325–1329 (2009).
Ali-Hasan-Al-Saegh, S. et al. Posterior pericardiotomy in cardiac surgery: systematic review and meta-analysis. Asian Cardiovasc. Thorac. Ann. 23, 354–362 (2015).
Hu, X. L. et al. Posterior pericardiotomy for the prevention of atrial fibrillation after coronary artery bypass grafting: A meta-analysis of randomized controlled trials. Int. J. Cardiol. 215, 252–256 (2016).
Kuralay, E., Ozal, E., Demirkili, U. & Tatar, H. Effect of posterior pericardiotomy on postoperative supraventricular arrhythmias and late pericardial effusion (posterior pericardiotomy). J. Thorac. Cardiovasc. Surg. 118, 492–495 (1999).
Farsak, B. et al. Posterior pericardiotomy reduces the incidence of supra-ventricular arrhythmias and pericardial effusion after coronary artery bypass grafting. Eur. J. Cardiothorac. Surg. 22, 278–281 (2002).
Asimakopoulos, G., Della Santa, R. & Taggart, D. P. Effects of posterior pericardiotomy on the incidence of atrial fibrillation and chest drainage after coronary revascularization: a prospective randomized trial. J. Thorac. Cardiovasc. Surg. 113, 797–799 (1997).
Calkins, H. Is less more for the treatment of atrial fibrillation after cardiac surgery? N. Engl. J. Med. 374, 1977–1978 (2016).
Butt, J. H. et al. Long-term thromboembolic risk in patients with postoperative atrial fibrillation after coronary artery bypass graft surgery and patients with nonvalvular atrial fibrillation. JAMA Cardiol. 3, 417–424 (2018).
Dunning, J. et al. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur. J. Cardiothorac. Surg. 30, 852–872 (2006).
Andrade, J. G. et al. 2018 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. Can. J. Cardiol. 34, 1371–1392 (2018).
January, C. T. et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 64, e1–e76 (2014).
Kirchhof, P. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 37, 2893–2962 (2016).
Fernando, H. C. et al. The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary. Ann. Thorac. Surg. 92, 1144–1152 (2011).
Frendl, G. et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J. Thorac. Cardiovasc. Surg. 148, e153–e193 (2014).
Zaman, A. G. et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 101, 1403–1408 (2000).
Zacharias, A. et al. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation 112, 3247–3255 (2005).
Banach, M. et al. Risk factors of atrial fibrillation following coronary artery bypass grafting: a preliminary report. Circ. J. 70, 438–441 (2006).
Shen, J. et al. The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. J. Thorac. Cardiovasc. Surg. 141, 559–570 (2011).
Brandt, M. C., Priebe, L., Bohle, T., Sudkamp, M. & Beuckelmann, D. J. The ultrarapid and the transient outward K+ current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation. J. Mol. Cell. Cardiol. 32, 1885–1896 (2000).
Dupont, E. et al. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 103, 842–849 (2001).
Wilhelm, M. et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation. Heart Lung Circ. 15, 30–37 (2006).
Kaireviciute, D. et al. Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation. J. Thromb. Haemost. 9, 2345–2352 (2011).
Yamac, A. H. et al. Altered expression of micro-RNA 199a and increased levels of cardiac SIRT1 protein are associated with the occurrence of atrial fibrillation after coronary artery bypass graft surgery. Cardiovasc. Pathol. 25, 232–236 (2016).